Company intelligence / Profile preview
Microviable Therapeutics
Gijón/Xixón, Asturias, Spainmicroviable.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Microviable Therapeutics develops next-generation live biotherapeutic products based on commensal human bacteria. Its lead program, MVT‑201—a cGMP-produced oral capsule representing a complete microbiota ecosystem—has shown positive preclinical results and was planned to enter clinical trials in late 2023. The company leverages its proprietary PharmaBiota® platform and a large strain collection to develop both full-microbiome and rationally designed consortia therapies targeting infectious diseases and other conditions. No published clinical trial results are available yet.
- Therapeutic areas
- OncologyGastroenterologyInfectious Diseases
- Modalities
- Live biotherapeutic products (LBPs)Complete microbiota ecosystem productsRationally defined bacterial consortia
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Inmunomet Intolerancias y Disbiosis SL
Beyond the preview
Go deeper on Microviable Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Microviable Therapeutics.